RESUMO
The aim of this study was to assess the risk factors and clinical and microbiological characteristics of community-acquired pneumonia (CAP) in adult patients in Mexico. Streptococcus pneumoniae classified as the causative agent of CAP in adult patients and patients with invasive S. pneumoniae isolates presented to three tertiary teaching hospitals during the 15-year study period were selected. Serotyping and susceptibility testing were performed for all included isolates. Clinical and demographic data were recorded. A total of 96 patients infected with S. pneumoniae (71 with CAP, 25 with invasive disease) were included. The CAP group involved more males (74.6%) than the invasive disease group (p = 0.03). Head trauma was more common in the CAP group (21.1%) than in the invasive disease group (4.0%; p = 0.03). The most prevalent serotype was 19A, followed by serotypes 3 and 23F. After the introduction of the heptavalent conjugated pneumococcal vaccine (PCV7), the prevalence of included serotypes declined significantly; no such change was found after the introduction of the PCV13 vaccine, including in the prevalence of serotype 19A. Susceptibility to all antimicrobials tested except vancomycin declined over the study period. In conclusion, head trauma was the most common comorbidity in the CAP group. The most prevalent serotype was 19A. Decreased susceptibility to most antimicrobials tested was observed.
El objetivo de este estudio fue evaluar los factores de riesgo y las características clínicas y microbiológicas de la neumonía adquirida en la comunidad (NAC) en pacientes adultos en México. Se seleccionaron pacientes adultos con NAC con Streptococcus pneumoniae como agente causal y pacientes con aislamientos invasivos de S. pneumoniae que concurrieron a tres hospitales de enseñanza de tercer nivel durante el período de estudio de 15 anos (2000-2015). Se realizaron pruebas de serotipificación y sensibilidad con todos los aislados incluidos. Se colectaron los datos clínicos y demográficos. Se incluyeron en total 96 pacientes infectados con S. pneumoniae (71 con NAC y 25 con enfermedad invasiva). El grupo con NAC incluía más varones (74,6%) que el grupo de enfermedad invasiva (p = 0,03). El traumatismo craneoencefálico fue más frecuente en el grupo NAC (21,1%) queen el grupo con enfermedad invasiva (4,0%; p = 0,03). El serotipo más frecuente fue 19A, seguido de los serotipos 3 y 23F. Después de la introducción de la vacuna antineumocócica conjugada heptavalente (PCV7), la prevalencia de los serotipos incluidos en aquella disminuyó significativamente; no sucedió lo mismo después de la introducción de la PCV13, incluso en relación con la prevalencia del serotipo 19A. La sensibilidad a todos los antimicrobianos evaluados, excepto la vancomicina, disminuyó durante el período de estudio. En conclusión, el traumatismo craneoencefálico fue la comorbilidad más frecuente en el grupo con NAC. El serotipo más frecuente fue el 19A, y se observó disminución de la sensibilidad a la mayoría de los antimicrobianos probados a lo largo del período considerado.
Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Pneumonia Pneumocócica/microbiologia , Streptococcus pneumoniae/isolamento & purificação , Infecções Comunitárias Adquiridas/microbiologia , Pneumonia Pneumocócica/epidemiologia , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/genética , Virulência , Resistência Microbiana a Medicamentos , Sorotipagem , Estudos Retrospectivos , Hospitais Privados/estatística & dados numéricos , Infecções Comunitárias Adquiridas/epidemiologia , Vacinas Pneumocócicas , Centros de Atenção Terciária/estatística & dados numéricos , Traumatismos Craniocerebrais/epidemiologia , Hospitais Públicos/estatística & dados numéricos , México/epidemiologiaRESUMO
Introducción: Streptoccocus pneumoniae es la causa más frecuente de neumonía bacteriana adquirida en la comunidad en la edad pediátrica. Objetivo: estimar la proporción de casos hospitalizados y defunciones por neumonía, así como describir la utilización de servicios de atención al paciente grave en niños con neumonía y sepsis. Métodos: se realizó un estudio retrospectivo de series de casos de niños entre 1 mes a 18 años, 2002-2013, así como datos de ingreso por neumonía (confirmada radiológicamente) y sepsis, en la Unidad de Terapia Intensiva 2011-2013, del Hospital Pediátrico Centro Habana. Resultados: se registraron un total de 5 672 ingresos por neumonía, para una media de 469 casos anuales, más frecuente en varones (53,2 por ciento) y niños entre 1 a 4 años (55,1 por ciento). Se registraron 14 fallecidos (0,25 por ciento del total), de los cuales 9 fueron del sexo masculino (64,3 por ciento). Entre 2011-2013, el 6 a 9 por ciento de los niños con neumonía requirieron ingreso en unidades de atención al grave, con predominio también de preescolares. Conclusiones: los datos obtenidos pueden aportar evidencia indirecta de la magnitud de la enfermedad neumocócica en un hospital pediátrico(AU)
Introduction: Streptococcus pneumoniae is the most common cause of community-acquired bacterial pneumonia at pediatric ages. Objective: to estimate the ratio of hospitalized cases and deaths of pneumonia as well as to describe the use of services to severely-ill patients in children with pneumonia and sepsis. Methods: retrospective case-series study performed in children aged one to 18 years from 2002 to 2013 and of hospitalization data for pneumonia (X ray-confirmed) and sepsis in the intensive care unit from 2011 to 2013 in Centro Habana pediatric hospital. Results: a total number of 5 672 admissions for pneumonia were registered, for a mean of 469 cases yearly, more frequent in males (53.2 percent) and children aged one to four years (55.1 percent). There were 14 deaths (0.25 percent of total number) and nine of them were males (64.3 percent). From 2011 to 2013, six to nine percent of children with pneumonia required admission to the severely-ill patient care unit with predominance of pre-school children. Conclusions: the collected data may provide indirect evidence for analysis of the magnitude of pneumococcal disease in a pediatric hospital(AU)
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Pneumonia Pneumocócica/mortalidade , Pneumonia Pneumocócica/epidemiologia , Relatos de Casos , Estudos Retrospectivos , HospitalizaçãoRESUMO
Abstract Objective: To describe and analyze the occurrence of hospitalizations for community-acquired pneumonia in children before and after the pneumococcal 10-valent conjugate vaccine implementation into the National Immunization Program. Methods: This is an ecological study that includes records of children younger than one year old, vaccinated and not vaccinated with the pneumococcal 10-valent conjugate vaccine in the periods pre- and post-inclusion of the vaccine in the National Immunization Program in the area covered by the Regional Health Superintendence of Alfenas, state of Minas Gerais, Brazil. Vaccination was considered as the exposure factor and hospitalization for community-acquired pneumonia as the endpoint, using secondary annual data by municipality. The prevalence ratio and its 95% confidence interval (95%CI) were used to verify the association between variables. The Z test was used to calculate the difference between proportions. Results: Considering the 26 municipalities of the Regional Health Superintendence of Alfenas, there was a significant reduction in hospitalizations for community-acquired pneumonia in children younger than one year of age, with prevalence ratio (PR)=0.81 (95%CI: 0.74-0.89; p<0.05), indicating a 19% lower prevalence of hospitalization for community-acquired pneumonia in the post-vaccination period. Conclusions: The results suggest the effectiveness of the pneumococcal 10-valent conjugate vaccine in preventing severe cases of community-acquired pneumonia in children younger than one year of age.
Resumo Objetivo: Descrever e analisar a ocorrência de internações por pneumonia adquirida na comunidade em crianças antes e após a implantação, no Programa Nacional de Imunização, da vacina pneumocócica 10-valente (conjugada). Métodos: Trata-se de um estudo ecológico que incluiu registros de crianças menores de um ano, vacinadas e não vacinadas com a vacina antipneumocócica 10-valente conjugada, no período pré e pós-inclusão da vacina no Programa Nacional de Imunização na área de abrangência da Superintendência Regional de Saúde de Alfenas, MG, Brasil. A vacinação foi considerada como fator de exposição e a hospitalização por pneumonia adquirida na comunidade como desfecho, com o uso de dados anuais secundários por município. Para verificar a associação entre as variáveis foi empregada a razão de prevalência e seu intervalo de confiança 95% (IC95%). Para o cálculo de diferença entre proporções empregou-se o teste Z. Resultados: Considerando os 26 municípios da Superintendência Regional de Saúde de Alfenas, houve redução significativa do número de hospitalização por pneumonia adquirida na comunidade em crianças abaixo de um ano, com razão de prevalência (RP)=0,81 (IC95% 0,74-0,89; p<0,05), o que indica uma prevalência de internação por pneumonia adquirida na comunidade 19% menor no período pós-vacinal. Conclusões: Os resultados sugerem a efetividade da vacina pneumocócica 10-valente (conjugada) na prevenção de casos graves da pneumonia adquirida na comunidade em crianças menores de um ano.
Assuntos
Humanos , Masculino , Feminino , Lactente , Pneumonia Pneumocócica/prevenção & controle , Pneumonia Pneumocócica/terapia , Vacinas Conjugadas , Vacinas Pneumocócicas , Hospitalização/estatística & dados numéricos , Pneumonia Pneumocócica/epidemiologia , Brasil/epidemiologia , Prevalência , Infecções Comunitárias Adquiridas/prevenção & controleRESUMO
Abstract Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two years of age. Between July/2010 and December/2013 we conducted a case-series study on invasive pneumococcal disease in Salvador, Brazil to describe the clinical and bacteriological profile of invasive pneumococcal disease cases during the post-implementation period. Eighty-two cases were eligible. Mean age was 31 years (interquartile range, 3–42); 17.1% and 30.5% were under 2 years and 5 years, respectively. Pneumococcal meningitis (n = 64, 78.1%), bacteraemic pneumococcal pneumonia (n = 12, 14.6%) and bacteraemia (n = 6, 7.3%) were the clinical syndromes identified. Thirty-three different serotypes were found. Of these, serotype 14 (n = 12, 14.6%) was the most common, followed by 23F (n = 10, 12.2%), 12F (n = 8, 9.8%), 18 C (n = 5, 6.1%) and 6B (n = 5, 6.1%). Investigations conducted in Salvador in the pre-vaccine period did not identify serotype 12F as one of the most prevalent serotypes. Increase of serotype 12F was observed in different regions of Brazil, in the post-vaccine period. Among children under two years of age, the target group for 10-valent pneumococcal conjugate vaccine, 11 (78.6%) of the 14 isolated strains of Streptococcus pneumoniae belonged to vaccine serotypes; at least 50% of these children were not vaccinated. The relatively recent implementation of 10-valent pneumococcal conjugate vaccine in Brazil reinforces the need to maintain an active surveillance of invasive pneumococcal disease cases, considering the possible increase of invasive pneumococcal disease cases related to non-vaccine serotypes and the changes on the clinical presentation of the disease.
Assuntos
Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Adulto Jovem , Bacteriemia/epidemiologia , Meningite Pneumocócica/epidemiologia , Vacinas Pneumocócicas/administração & dosagem , Pneumonia Pneumocócica/epidemiologia , Streptococcus pneumoniae/imunologia , Bacteriemia/microbiologia , Bacteriemia/prevenção & controle , Brasil/epidemiologia , Meningite Pneumocócica/microbiologia , Meningite Pneumocócica/prevenção & controle , Prevalência , Vacinas Pneumocócicas/imunologia , Pneumonia Pneumocócica/microbiologia , Pneumonia Pneumocócica/prevenção & controle , Estudos RetrospectivosRESUMO
Introducción: El Streptococcus pneumoniae (S. pneumoniae), también denominado neumococo, es una de las principales bacterias asociadas a mortalidad en menores de 2 años, con una incidencia de morbimortalidad variable de acuerdo a la demografía y exposición a factores protectores o de riesgo. Objetivo: Caracterizar los pacientes fallecidos por enfermedad neumocóccica invasiva (ENI) entre el 2008-2014 en la población infantil de 8 instituciones de salud en Bogotá, Colombia. Pacientes y método: Estudio observacional descriptivo tipo serie de casos, en pacientes fallecidos por ENI, mayores de 28 días hasta los 18 años, en 8 instituciones de tercer nivel de atención en Bogotá, Colombia. Periodo del estudio del 1 de enero de 2008 al 15 de enero de 2014. Tamaño de la muestra: 239 pacientes. Resultados: Se revisaron 239 casos registrados de ENI, presentando una mortalidad del 7,5% (n = 18). La edad promedio de los pacientes que fallecieron fue de 43,7 meses, con un rango de edad entre 2 y 176 meses (14 años); el 66% de los casos era de sexo masculino. Se identificaron serotipos en 8 pacientes, encontrando: 6A, 6B, 10A, 14, 18C, 23B, 23F, 35B. La presentación clínica más frecuente de los casos de mortalidad fue meningitis con el 33% (6 casos), seguida por bacteriemia sin foco en el 28% (5 casos) y neumonía con el 27% (5 casos). Se presentaron situaciones clínicas combinadas como neumonía y meningitis en el 11% (2 casos). Dos de los pacientes tenían factores de riesgo para ENI claramente documentados (asplenia y enfermedad respiratoria crónica). Conclusiones: La mortalidad por ENI es especialmente alta en los menores de 2 años y en pacientes de sexo masculino, especialmente cuando presenta foco meníngeo (44%). La serotipificación no fue posible en todos los pacientes fallecidos, ya que no se envió la cepa aislada al Instituto Nacional de Salud. Se requiere una vigilancia continua y sistemática para evaluar el impacto de la vacunación y las posibles modificaciones en el patrón de presentación de la enfermedad.
Introduction: Streptococcus pneumoniae (S. pneumoniae), also known as pneumococcus, is one of the main bacteria associated with mortality in children under 2 years of age, with a morbidity and mortality incidence that varies according to demographics and exposure to risk, or protective factors. Objective: To describe the child mortality due to invasive pneumococcal disease (IPD) between 2008 -2014 (6 years), in 8 Medical Centres in Bogotá, Colombia. Patients and method: Descriptive observational case series of patients who died of IPD, aged 28 days to 18 years, in 8 tertiary care institutions in Bogota, Colombia. The study period was from 1 January 2008 to 15 January 2014. Sample size: 239 patients. Results: A total of 239 registered cases of IPD were reviewed, showing a mortality of 8% (n 18). The mean age of patients that died was 43.7 months, with an age range from 2 to 176 months (14 years), with 66% of the cases being male. Serotypes were identified in 8 patients, finding: 6A, 6B, 10A, 14, 18C, 23B, 23F, and 35B. The most common clinical presentation of the cases was meningitis with mortality of 33% (6 cases), followed by bacteraemia without focus in 28% (5 cases), and pneumonia with 27% (5 cases). Combined clinical situations were presented, such as pneumonia and meningitis in 11% (2 cases). Two of the patients had clearly documented risk factors for IPD (asplenia and chronic respiratory disease). Conclusions: IPD mortality is particularly high in children under 2 years in male patients, especially when presented with a meningeal focus (44%). Serotyping was not possible in all patients who died, since no strain isolated was sent to the National Institute of Health. Continuous and systematic vigilance is required to evaluate the impact of vaccination and possible changes in the pattern of presentation of disease.
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Pneumonia Pneumocócica/mortalidade , Streptococcus pneumoniae/isolamento & purificação , Bacteriemia/mortalidade , Meningite Pneumocócica/mortalidade , Pneumonia Pneumocócica/epidemiologia , Sorotipagem , Fatores Sexuais , Incidência , Estudos Retrospectivos , Fatores de Risco , Bacteriemia/microbiologia , Bacteriemia/epidemiologia , Colômbia/epidemiologia , Meningite Pneumocócica/epidemiologiaRESUMO
La neumonía adquirida en la comunidad (NAC) en adultos es causa frecuente de morbilidad y mortalidad, especialmente en adultos mayores y en sujetos con comorbilidades previas. La mayoría de los episodios son de etiología bacteriana, Streptococcus pneumoniae es el patógeno aislado con mayor frecuencia. La vigilancia epidemiológica permite conocer los cambios en los microorganismos productores y su sensibilidad a los antimicrobianos; recientemente se ha observado un incremento en aislamientos de Staphylococcus aureus resistente a la meticilina y Legionella sp. La radiografía de tórax resulta imprescindible como herramienta diagnóstica. El score CURB-65 y la oximetría de pulso permiten estratificar a los pacientes en aquellos que requieren manejo ambulatorio, hospitalización en sala general o unidad de terapia intensiva. Los estudios diagnósticos y el tratamiento antimicrobiano empírico también se basan en esta estratificación. Los biomarcadores tales como procalcitonina o proteína-C reactiva no son parte de la evaluación inicial dado que su utilización no demostró modificar el manejo de los episodios de NAC. El tratamiento antibiótico sugerido para pacientes ambulatorios menores de 65 años sin comorbilidades es amoxicilina; pacientes ≥ 65 años o con comorbilidades: amoxicilina-clavulánico/sulbactam; hospitalizados en sala general: ampicilina sulbactam con o sin claritromicina; pacientes admitidos a unidad de terapia intensiva: ampicilina-sulbactam más claritromicina. La duración del tratamiento es de 5 a 7 días para tratamiento ambulatorio y 7 a 10 para los hospitalizados. En época de circulación del virus de la influenza se sugiere el agregado de oseltamivir para los pacientes hospitalizados y para aquellos con comorbilidades.
Community-acquired pneumonia in adults is a common cause of morbidity and mortality particularly in the elderly and in patients with comorbidities. Most episodes are of bacterial origin, Streptococcus pneumoniae is the most frequently isolated pathogen. Epidemiological surveillance provides information about changes in microorganisms and their susceptibility. In recent years there has been an increase in cases caused by community-acquired meticillin resistant Staphylococcus aureus and Legionella sp. The chest radiograph is essential as a diagnostic tool. CURB-65 score and pulse oximetry allow stratifying patients into those who require outpatient care, general hospital room or admission to intensive care unit. Diagnostic studies and empirical antimicrobial therapy are also based on this stratification. The use of biomarkers such as procalcitonin or C-reactive protein is not part of the initial evaluation because its use has not been shown to modify the initial approach. We recommend treatment with amoxicillin for outpatients under 65 year old and without comorbidities, for patients 65 years or more or with comorbidities amoxicillin-clavulanic/sulbactam, for patients hospitalized in general ward ampicillin-sulbactam with or without the addition of clarithromycin, and for patients admitted to intensive care unit ampicillin-sulbactam plus clarithromycin. Suggested treatment duration is 5 to 7 days for outpatients and 7 to 10 for those who are hospitalized. During the influenza season addition of oseltamivir for hospitalized patients and for those with comorbidities is suggested.
Assuntos
Humanos , Adulto , Pessoa de Meia-Idade , Idoso , Pneumonia Pneumocócica/diagnóstico , Pneumonia Pneumocócica/microbiologia , Pneumonia Pneumocócica/tratamento farmacológico , Pneumonia Pneumocócica/epidemiologia , Streptococcus pneumoniae , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/microbiologia , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/epidemiologia , Antibacterianos/uso terapêuticoRESUMO
Introducción: Streptococcus pneumoniae es la primera causa de neumonía bacteriana en niños, principalmente en hospitalizados. La vacuna antineumocócica 10-valente fue introducida al Programa Nacional de Inmunizaciones de Chile el año 2011. El objetivo de este estudio fue determinar la incidencia de egresos por neumonía en niños < 24 meses en el Hospital Dr. Luis Calvo Mackenna, Santiago, Chile, antes y después de la implementación de vacuna antineumocócica 10-valente en el Programa Nacional de Inmunizaciones. Pacientes y método: Estudio de vigilancia pasiva; se estudiaron los pacientes < 24 meses egresados desde el Hospital Dr. Luis Calvo Mackenna entre los años 2009-2013 con diagnóstico de neumonía bacteriana. Los datos fueron obtenidos desde el Servicio de Estadística del Hospital Dr. Luis Calvo Mackenna. Se evaluó la incidencia de neumonía durante el período prevacuna (2009-2010) y posvacuna (2012-2013). Resultados: Durante el período de estudio se observó un promedio de 4.321 egresos/año en niños < 24 meses (rango: 3.587-4.702), con una disminución significativa desde el período pre- al posvacuna (4.644 versus 4.013; p < 0,001). La incidencia media de egresos por neumonía varió de 3,4/100.000 a 1,5/100.000 en el período pre- y posvacuna, respectivamente (p = 0,009), con un promedio anual de casos de neumonía de 157 en el primer período y de 62 en el segundo (p < 0,001) y una disminución de incidencia entre ambos períodos del 56%. Conclusión: Este estudio corrobora la información obtenida en otros países, mostrando una disminución en la incidencia de neumonía al implementar la vacuna antineumocócica a nivel poblacional. Es necesaria una vigilancia permanente para evaluar si este efecto se mantiene en el tiempo y se expande a poblaciones de mayor edad.
Introduction: Streptococcus pneumoniae is the leading cause of bacterial pneumonia in children, especially in the hospitalized population. The 10-valent pneumococcal vaccine was included in the National Immunization Program of Chile in 2011. This study aims to evaluate the incidence of pneumonia in hospitalized children < 24 months of age in the Luis Calvo Mackenna Hospital before and after the introduction of the pneumococcal vaccine into the National Immunization Program. Patients and methods: Passive surveillance study. Patients < 24 months with discharge diagnosis of bacterial pneumonia from Luis Calvo Mackenna Hospital were studied between 2009 and 2013. Data were obtained from the Luis Calvo Mackenna Hospital's Statistical Service. The incidence of pneumonia was evaluated in the pre-vaccination period (2009-2010) and in the post-vaccination period (2012-2013). Results: During the study period, an average of 4,321 discharges/year was observed in children < 24 months (range: 3,587-4,702), with a significant decrease from pre- to post-vaccination vaccine period (4,644 vs 4,013, P < .001). The average incidence of pneumonia ranged from 3.4/100,000 to 1.5/100,000 in the pre- and post-vaccine period, respectively (P = .009), with an annual mean of 157 cases of pneumonia in the pre-vaccine period, and 62 cases in the postvaccine period (P < .001) and a decrease in incidence between the two periods of 56%. Conclusion: This study confirms information previously obtained in other countries, which show a decrease in the incidence of pneumonia associated with the implementation of a pneumococcal vaccine at the population level. Ongoing surveillance is required to evaluate if this effect is maintained over time and expands to older populations.
Assuntos
Humanos , Masculino , Feminino , Lactente , Pneumonia Pneumocócica/epidemiologia , Programas de Imunização , Pneumonia Bacteriana/epidemiologia , Vacinas Pneumocócicas/administração & dosagem , Pneumonia Pneumocócica/prevenção & controle , Streptococcus pneumoniae/isolamento & purificação , Chile/epidemiologia , Incidência , Estudos Retrospectivos , Vacinação , Pneumonia Bacteriana/microbiologia , Pneumonia Bacteriana/prevenção & controle , HospitalizaçãoRESUMO
Streptococcus pneumoniae is the most common bacterial cause of pneumonia in children and has become a topic of controversy for epidemiological changes that have been seen in recent years with the advent of the vaccine and the emergence of serotypes that cause increased morbidity which were not covered by the heptavalent vaccine. Also there have been changes in the concepts of resistance in recent years. This has led to the reevaluation of the use of specific antibiotics for management.
El Streptococcus pneumoniae es la causa bacteriana más frecuente de neumonía en los niños y se ha convertido en un tema de controversia por los cambios epidemiológicos que se han visto en los últimos años con el advenimiento de la vacuna y el surgimiento de serotipos que causan mayor morbilidad que no estaban cubiertos por la vacuna heptavalente. Igualmente se han presentado cambios en los conceptos de resistencia en los últimos años. Esto ha motivado la reevaluación del uso de los antibióticos específicos para su manejo.
Assuntos
Humanos , Criança , Resistência Microbiana a Medicamentos , Pneumonia Pneumocócica/tratamento farmacológico , Antibacterianos/uso terapêutico , Colômbia , Saúde Global , Pneumonia Pneumocócica/epidemiologia , Resistência às Penicilinas , Streptococcus pneumoniaeRESUMO
OBJECTIVE: To determine the epidemiology of invasive pneumococcal disease (IPD) and the antibiotic susceptibility and serotype distribution of S. pneumoniae in pediatric patients in Lima, Peru. METHODS: A 2-year, multicenter, passive surveillance study conducted from May 2006- April 2008 in 11 public hospitals and five private laboratories in Lima, Peru, in patients less than 16 years of age with sterile site cultures yielding S. pneumoniae. Antibiotic susceptibility was performed by Etest® (AB Biodisk, Solna, Switzerland). Strains were serotyped by the Quellung reaction. RESULTS: In all, 101 IPD episodes were studied, 68.3 percent of which were among children less than 24 months of age. Diagnoses were: pneumonia (47.5 percent), meningitis (38.6 percent), and sepsis (7.9 percent). The overall case fatality rate was 22.0 percent; case fatality rate in meningitis was 32.4 percent. While 80.0 percent of fatal cases were in those less than 24 months of age, only 50.7 percent of non-fatal cases (P < 0.05) were in this age group. Resistance rates were high for trimethoprim/ sulfamethoxazole (76.2 percent), erythromycin (24.8 percent), and penicillin (22.8 percent). The most common serotypes were 14, 6B, 19F, 23F, and 5, which accounted for 69.7 percent of all strains and 87.0 percent of penicillin non-susceptible strains. CONCLUSIONS: IPD in hospitalized children in Lima is associated with high antimicrobial resistance levels and elevated case fatality rate, especially in young children. This baseline data will be useful for evaluating the effects of vaccine introduction.
OBJETIVO: Determinar la epidemiología de la enfermedad neumocócica invasora y la sensibilidad a los antibióticos y la distribución de los serotipos de S. pneumoniae en pacientes pediátricos en Lima, Perú. MÉTODOS: Estudio multicéntrico de vigilancia pasiva durante dos años, entre mayo del 2006 y abril del 2008, en 11 hospitales públicos y 5 consultorios privados de Lima, en pacientes menores de 16 años con cultivos de sitios estériles positivos para S. pneumoniae. Se determinó la sensibilidad a los antibióticos mediante Etest® (AB Biodisk, Solna, Suiza). Se serotipificaron las cepas mediante la reacción de Quellung. RESULTADOS: En total, se estudiaron 101 episodios de enfermedad neumocócica invasora, 68,3 por ciento de ellos en niños menores de 24 meses, con los siguientes diagnósticos: neumonía (47,5 por ciento), meningitis (38,6 por ciento) y septicemia (7,9 por ciento). La tasa de letalidad general fue de 22,0 por ciento y la tasa de letalidad por meningitis de 32,4 por ciento. Si bien 80,0 por ciento de los casos mortales ocurrió en menores de 24 meses, solo 50,7 por ciento de los casos no mortales (P < 0,05) ocurrió en este grupo de edad. Las tasas de resistencia fueron elevadas para trimetoprima-sulfametoxazol (76,2 por ciento), eritromicina (24,8 por ciento) y penicilina (22,8 por ciento). Los serotipos más comunes, 14, 6B, 19F, 23F y 5, representaron 69,7 por ciento de todas las cepas, y 87,0 por ciento de las cepas no sensibles a la penicilina. CONCLUSIONES: La enfermedad neumocócica invasora en niños hospitalizados en Lima se asocia con altos niveles de resistencia a los antimicrobianos y una tasa de letalidad elevada, especialmente en niños pequeños. Estos datos iniciales serán útiles para evaluar los efectos de la introducción de las vacunas.
Assuntos
Humanos , Lactente , Pré-Escolar , Criança , Adolescente , Criança Hospitalizada/estatística & dados numéricos , Infecções Pneumocócicas/epidemiologia , Infecção Hospitalar/epidemiologia , Farmacorresistência Bacteriana , Mortalidade Hospitalar , Hospitais Públicos/estatística & dados numéricos , Incidência , Laboratórios/estatística & dados numéricos , Meningite Pneumocócica/epidemiologia , Meningite Pneumocócica/microbiologia , Peru/epidemiologia , Vacinas Pneumocócicas , Pneumonia Pneumocócica/epidemiologia , Pneumonia Pneumocócica/microbiologia , Vigilância da População , Estudos Prospectivos , Sepse/epidemiologia , Sepse/microbiologia , Sorotipagem , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/isolamento & purificação , População Urbana/estatística & dados numéricosRESUMO
Objetivo Estimar el impacto de la enfermedad por Streptococcus pneumoniae en la población mayor de 60 años en Bogotá D.C. Colombia. Métodos Se realizó un estudio de impacto de enfermedad por neumococo combinando una búsqueda sistemática de literatura con el análisis de fuentes de datos rutinarios de mortalidad, consultas y hospitalizaciones debidas neumonías y meningitis en adultos mayores de 60 años. Resultados Se estimó para 2008 en la población bogotana mayor de 60 años la ocurrencia de 6 585 neumonías por todos los agentes, 689 debidas a Streptococcus pneumoniae, y 73 meningitis, 12 producidas por neumococo. El total de muertes por neumonías se estimó en 1 910, 82 atribuibles al neumococo, y de las 40 muertes por meningitis, 7 habrían ocurrido en casos de meningitis neumocócicas. Conclusiones El impacto de la enfermedad debida a neumococo en población mayor de 60 años en Bogotá justifica la consideración de estrategias específicas de prevención tales como la vacunación.
Objective Estimating the impact of pneumococcal disease amongst adults living in Bogota, Colombia Methods The impact of pneumococcal disease was studied by combining a systematic literature search with analysing routine sources regarding mortality, consultation and hospitalisation dates due to pneumonia and meningitis. Results The occurrence of 6,585 cases of pneumonia by all germs was estimated for 2008 in the adult population aged over 60, 689 cases being due to Streptococcus pneumonia, and 73 cases of meningitis, plus 12 cases caused by pneumococcus. The total of deaths from pneumonia was estimated to be 1,910 cases (82 due to pneumonia) and 40 deaths occurred from meningitis (7 of these cases being due to pneumococcal meningitis). Conclusiones The impact of pneumococcal disease in adults aged over 60 in Bogota (only taking into account cases of meningitis and pneumonia with blood and CSF isolates) justifies considering specific prevention strategies such as vaccination.
Assuntos
Idoso , Humanos , Pessoa de Meia-Idade , Infecções Pneumocócicas/epidemiologia , Colômbia/epidemiologia , Hospitalização/estatística & dados numéricos , Incidência , Meningite Pneumocócica/epidemiologia , Visita a Consultório Médico/estatística & dados numéricos , Pneumonia Pneumocócica/epidemiologia , População Urbana/estatística & dados numéricosRESUMO
Background :Invasive pneumococcal disease (IPD) is vaccine-preventable but few data on the incidence of PD exist for Indian children. Aims: To assess the feasibility of implementing prospective, population-based surveillance for PD among children less than five years of age. Settings and Design :Hospitals and health agencies, Bangalore, India. Retrospective review and analysis of hospitalization records as well as public health and demographic data. Material and Methods : Records for 2006 hospitalizations for pneumococcal disease-associated syndromes (meningitis, pneumonia and sepsis) were identified at three pediatric referral hospitals (Indira Gandhi Institute of Child Health, Kempegowda Institute of Child Health and Vani Vilas Hospital) in Bangalore using International Classification of Diseases, 9th revision codes. Hospital microbiology laboratory records were assessed to ensure capacity for identifying S. pneumoniae. Population data were identified from national census and polio surveillance data. Results : The Bangalore city southern zone includes 33 wards occupying 51 Km 2 with 150,945 children between 0-5 years of age served by three referral pediatric hospitals. From January--December 2006, records of these three hospitals showed 2,219 hospitalizations of children less than five years of age (967 pneumonia, 768 sepsis, and 484 meningitis) with PD-associated diagnoses (southern zone area incidence: 0.15/100,000 PD-associated hospitalizations, less than five years of age). There were 178 deaths in children less than five years of age, of which 87 were attributable to sepsis, 56 to pneumonia and 35 to meningitis. Conclusion : Our analysis suggests that the PD-associated disease burden in Bangalore is high and local institutions have capacity for population-based surveillance. In a prospective study, systematic attention to potential barriers in identifying children with pneumococcal infections will improve estimation of IPD incidence in India.
Assuntos
Fatores Etários , Pré-Escolar , Estudos de Viabilidade , Feminino , Humanos , Incidência , Índia/epidemiologia , Lactente , Recém-Nascido , Masculino , Meningite Pneumocócica/epidemiologia , Meningite Pneumocócica/microbiologia , Meningite Pneumocócica/prevenção & controle , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/prevenção & controle , Pneumonia Pneumocócica/epidemiologia , Pneumonia Pneumocócica/microbiologia , Pneumonia Pneumocócica/prevenção & controle , Grupos Populacionais , Estudos Retrospectivos , Vigilância de Evento Sentinela , Sepse/epidemiologia , Sepse/microbiologia , Sepse/prevenção & controle , Streptococcus pneumoniae/isolamento & purificaçãoRESUMO
Objetivo: Describir la frecuencia y tipo de enfermedad neumocóccica invasora (ENI) y neumonía consolidante (NC) en lactantes chilenos. Pacientes y Métodos: Vigilancia prospectiva durante un año en tres centros. Vigilancia de ENI: hemocultivo en lactantes con sospecha clínica de enfermedad bacteriana invasora (EBI) o fiebre > 39 °C axilar, sin foco o con otitis media aguda. Vigilancia de NC: hemocultivo y evaluación independiente de la radiografía en lactantes con sospecha clínica de neumonía. Resultados: ENI: en 4.369 lactantes enrolados se detectaron 58 casos de EBI, 37 (64 por ciento) por Streptococcus pneumoniae. Tasas de ENI: 110/100.000 (Chillan) y 288/100.000 (Valparaíso). Serotipos de S. pneumoniae identificados: 18C (n: 8), 14 (n: 8), 19A (n: 5), otros (n: 12). NC: en 3.005 niños enrolados se detectaron 762 NC. Tasas de NC: 2.918/ 100.000 (Chillan) y 5.547/100.000 (Valparaíso). Discusión: Se confirma la relevancia de S. pneumoniae como agente de EBI así como la elevada frecuencia de NC en lactantes en Chile.
Objective: To describe frequency and type of invasive pneumococcal diseases (IPD) and consolidated pneumonia (CP) in Chilean infants. Patients and Methods: One-year prospective surveillance in three health care centers. PID surveillance: blood culture in infants with suspected invasive bacterial disease or with fever higher than 39°C axillary without focus or with acute otitis media. CP surveillance: blood culture and independent evaluation of chest X-ray in infants with suspected pneumonia. Results: IPD: in 4,369 infants studied, 58 cases of invasive bacterial diseases were identified, 37 (64 percent) due to S. pneumoniae. Rates of IPD: 110/100,000 (Chilian) and 288/100,000 (Valparaiso). Serotypes identified: 18C(n: 8), 14 (n: 8), 19A(n: 5), others (n: 12). CP: in 3,005 infants 762 CP were detected. Rates of CP: 2,918/100,000 (Chilian) and 5,547/100,000 (Valparaiso). Discussion: Results support the relevance of S. pneumoniae as the main cause of invasive bacterial disease and the high frequency of CP in this age group in Chile.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Infecções Pneumocócicas/epidemiologia , Vigilância da População/métodos , Streptococcus pneumoniae , Antibacterianos/uso terapêutico , Chile/epidemiologia , Estudos Prospectivos , Infecções Pneumocócicas/classificação , Infecções Pneumocócicas/diagnóstico , Pneumonia Pneumocócica/diagnóstico , Pneumonia Pneumocócica/epidemiologia , Sorotipagem , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificaçãoRESUMO
OBJECTIVE: To determine the epidemiology of Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae invasive infections in hospitalized Guatemalan children. This is an important issue since Hib vaccine has not been incorporated into the routine immunization program in Guatemala and information from hospital records in 1995 indicated a low incidence of Hib and S. pneumoniae as causes of meningitis and invasive infections. METHODS: Children who were hospitalized in Guatemala City with clinical signs compatible with bacterial infections were evaluated for evidence of Hib or S. pneumoniae infection. Normally sterile body fluids were cultured, and antigen detection was performed on cerebrospinal fluid (CSF) and pleural fluid. RESULTS: Of 1 203 children 1-59 months of age hospitalized over a 28-month period, 725 of them (60.3 percent) had a primary diagnosis of pneumonia, 357 (29.7 percent) of meningitis, 60 (5.0 percent) of cellulitis, and 61 (5.1 percent) of sepsis and other conditions. Hib was identified in 20.0 percent of children with meningitis and S. pneumoniae in 12.9 percent. The average annual incidence of Hib meningitis was 13.8 cases per 100 000 children under 5 years of age, and 32.4 percent of meningitides caused by Hib and 58.7 percent of S. pneumoniae meningitides occurred prior to 6 months of age. Case fatality rates were 14.1 percent, 37.0 percent, and 18.0 percent, respectively, for children with Hib, S. pneumoniae, and culture-negative and antigen-negative meningitis. Prior antibiotic therapy was common and was associated with significant reductions in CSF-culture-positive results for children with other evidence of Hib or S. pneumoniae meningitis. CONCLUSIONS: Improvements in case detection, culture methods, and latex agglutination for antigen detection in CSF resulted in identification of Hib and S. pneumoniae as important causes of severe disease in Guatemalan children. Using a cutoff of > 10 white blood cells per cubic millimeter in CSF would improve the sensitivity for detection of bacterial meningitis and help estimate the burden of bacterial meningitis in Guatemala and other developing countries.
Objetivo. Determinar las características epidemiológicas de las infecciones invasoras por Haemophilus influenzae tipo b (Hib) y Streptococcus pneumoniae en niños hospitalizados en Guatemala. La importancia de este tema radica en que la vacunación contra Hib no ha sido incorporada a los programas de inmunización establecidos en Guatemala y en que los registros hospitalarios de 1995 indicaban una baja incidencia de meningitis e infecciones invasoras causadas por Hib y S. pneumoniae. Métodos. Los niños hospitalizados en la Ciudad de Guatemala con signos clínicos de infección bacteriana se estudiaron en busca de indicios de infección por Hib o S. pneumoniae. Se cultivaron líquidos corporales normalmente estériles y se hicieron pruebas de detección de antígenos en líquidos cefalorraquídeo (LCR) y pleural. Resultados. De los 1 203 niños de 1 a 59 meses de edad hospitalizados en un período de 28 meses, 725 (60,3%) tenían un diagnóstico primario de neumonía, 357 (29,7%) de meningitis, 60 (5,0%) de celulitis y 61 (5,1%) de sepsis u otras afecciones. En 20,0% de los niños con meningitis se detectó Hib y en 12,9% S. pneumoniae. La incidencia media anual de meningitis por Hib fue de 13,8 casos por 100 000 niños menores de 5 años de edad; 32,4% de los casos de meningitis causados por Hib y 58,7% de los causados por S. pneumoniae ocurrieron en niños menores de 6 meses de edad. La tasa de letalidad fue de 14,1%, 37,0% y 18,0%, respectivamente, para los casos de meningitis por Hib, por S. pneumoniae y con resultados negativos tanto en el cultivo como en las pruebas de detección de antígeno. El tratamiento previo con antibióticos fue frecuente y se vio asociado con una reducción significativa de resultados positivos en el cultivo de LCR en los niños que presentaban otros signos de meningitis por Hib o S. pneumoniae. Conclusiones. El perfeccionamiento de la detección de casos, los métodos de cultivo y las pruebas de aglutinación con látex para la detección antigénica en LCR permitió identificar a Hib y S. pneumoniae como causas importantes de enfermedades graves en niños guatemaltecos. El empleo de un punto de corte de más de 10 leucocitos por milímetro cúbico de LCR mejoraría la sensibilidad de la detección de la meningitis bacteriana y ayudaría a calcular la carga de esta enfermedad en Guatemala y otros países en desarrollo.
Assuntos
Humanos , Lactente , Pré-Escolar , Meningite por Haemophilus/epidemiologia , Pneumonia Pneumocócica/epidemiologia , Guatemala/epidemiologia , Haemophilus influenzae , Hospitalização , Incidência , Meningite por Haemophilus/diagnóstico , Pneumonia Pneumocócica/diagnóstico , Sepse/epidemiologia , Streptococcus pneumoniaeRESUMO
Introducción: la neumonía bacteriana es causa frecuente de internación en pediatría. En Uruguay se utiliza, desde 1997, una pauta de tratamiento adaptada a la realidad epidemiológica. Objetivos: describir las características clínicas, radiológicas y etiológicas de los niños ingresados con diagnóstico de neumonía bacteriana adquirida en la comunidad y evaluar el cumplimiento y vigencia de la pauta de tratamiento con penicilina y derivados y/o macrólidos. Método: entre el 19 de mayo de 1999 y el 18 de mayo de 2000 se estudiaron en forma prospectiva los niños, entre un mes y 14 años de edad, ingresados con diagnóstico de neumonía bacteriana adquirida en la comunidad al Centro Hospitalario Pereira Rossell. Se realizó al ingreso radiografía de tórax, hemocultivo y estudio del líquido pleural cuando correspondió. Se trataron de acuerdo a la pauta. Resultados: se incluyeron 697 niños (7,7 por ciento del total de egresos del período). Predominaron los menores de cinco años. La radiografía de tórax mostró bloque de consolidación homogénea en 95 por ciento. Se confirmó la causa bacteriana en 77 niños, 76 correspondieron a S. pneumoniae, predominaron los serotipos 5, 14 y 1; las cuatro cepas resistentes a penicilina (CIM mayor igual 2 @g/ml) correspondieron al serotipo 14. El 16 por ciento de los niños presentó empiema. El 93 por ciento de los pacientes se trató según la pauta. Fallecieron ocho niños; en cuatro se identificó S.pneumoniae no resistente a penicilina. Conclusiones: la pauta de tratamiento mantiene su vigencia. Se necesitan estudios para identificar factores de riesgo de empiema. Para disminuir la morbimortalidad por neumonía se requiere reforzar las acciones en el primer nivel de atención y conocer los serotipos de S.pneumoniae prevalentes con vistas a la posible aplicación de una vacuna.
Assuntos
Humanos , Pré-Escolar , Adolescente , Recém-Nascido , Lactente , Criança , Pneumonia Bacteriana/diagnóstico , Pneumonia Bacteriana/etiologia , Pneumonia Bacteriana/tratamento farmacológico , Infecções Comunitárias Adquiridas , Empiema , Pneumonia Bacteriana/epidemiologia , Pneumonia Pneumocócica/diagnóstico , Pneumonia Pneumocócica/epidemiologia , Pneumonia Pneumocócica/terapia , UruguaiRESUMO
This study attempted to identify the determinants of acute lower respiratory-tract infections (ALRI) among children under five years of age, by comparing hundred children hospitalized with ALRI with a control group. Data on socio-demographic, biological and environmental characteristics were collected by interviewing mothers and anthropometric measurements were carried out to assess the nutritional status of the children. Risk of disease in the presence of each exposure was calculated in the univariate analysis and the best explanatory variables among them were identified in the multivariate analysis. The following variables were found to increase the risk of ALRI: (1) history of wheezing, (2) low birth weight, (3) passive smoking, (4) male sex, (5) delivery by cesarean section (6) sharing of sleeping space, (7) not being exclusively breast fed upto the completion of four months, (8) stunting, (9) having pets. The findings highlight some simple strategies which would help in prevention of ALRI.